文献检索，用中文搜 PubMed

1

Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study).勘误：匹伐他汀和ω-3脂肪酸乙酯对接受他汀类药物治疗的血脂异常患者载脂蛋白B-48的影响：一项在日本进行的前瞻性、多中心、开放标签、随机、平行组试验（PROUD48研究）。

Front Cardiovasc Med. 2023 Mar 16;10:1172664. doi: 10.3389/fcvm.2023.1172664. eCollection 2023.

2

The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study).匹马贝特和ω-3脂肪酸乙酯对接受他汀类药物治疗的血脂异常患者载脂蛋白B-48的影响：一项在日本进行的前瞻性、多中心、开放标签、随机、平行组试验（PROUD48研究）。

Front Cardiovasc Med. 2023 Jan 25;10:1094100. doi: 10.3389/fcvm.2023.1094100. eCollection 2023.

3

Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan.PROUD48 研究方案：比较贝特类药物和 ω-3 脂肪酸乙酯对他汀类药物治疗伴血脂异常患者 ApoB-48 的影响：日本一项前瞻性、多中心、开放标签、随机、平行分组试验。

BMJ Open. 2022 Nov 14;12(11):e061360. doi: 10.1136/bmjopen-2022-061360.

4

Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD).一项评估匹伐他汀对慢性肾脏病（CKD）患者蛋白尿影响的开放标签、随机对照试验（PROFIT-CKD）的设计与方法

Clin Exp Nephrol. 2023 Apr;27(4):358-364. doi: 10.1007/s10157-023-02322-4. Epub 2023 Feb 4.

5

ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia.ω-3脂肪酸乙酯可减轻家族性高胆固醇血症患者的餐后血脂异常。

J Clin Endocrinol Metab. 2016 Oct;101(10):3732-3739. doi: 10.1210/jc.2016-2217. Epub 2016 Aug 4.

6

Substitution of dietary ω-6 polyunsaturated fatty acids for saturated fatty acids decreases LDL apolipoprotein B-100 production rate in men with dyslipidemia associated with insulin resistance: a randomized controlled trial.用膳食 ω-6 多不饱和脂肪酸替代饱和脂肪酸可降低伴有胰岛素抵抗的血脂异常男性 LDL 载脂蛋白 B-100 的生成率：一项随机对照试验。

Am J Clin Nutr. 2018 Jan 1;107(1):26-34. doi: 10.1093/ajcn/nqx013.

7

Effect of omega-3 fatty acids on cardiovascular events in high-risk patients with hypertriglyceridemia in Japan: a 3-year post-marketing surveillance study (OCEAN3 survey).ω-3脂肪酸对日本高甘油三酯血症高危患者心血管事件的影响：一项为期3年的上市后监测研究（OCEAN3调查）

Expert Opin Drug Saf. 2023 Jan;22(1):81-90. doi: 10.1080/14740338.2022.2094914. Epub 2022 Jul 8.

8

A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).一种高生物利用度的ω-3 游离脂肪酸配方可改善高风险、他汀类药物治疗后仍存在高甘油三酯血症的患者的心血管风险特征（ESPRIT 试验）。

Clin Ther. 2013 Sep;35(9):1400-11.e1-3. doi: 10.1016/j.clinthera.2013.07.420. Epub 2013 Aug 30.

9

N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.N-3 多不饱和脂肪酸改善日本 2 型糖尿病伴高甘油三酯血症患者的脂蛋白颗粒大小和浓度：一项初步研究。

Lipids Health Dis. 2018 Mar 15;17(1):51. doi: 10.1186/s12944-018-0706-8.

10

Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial.在他汀类药物治疗后仍存在高甘油三酯血症的患者中添加欧米伽-3 脂肪酸的疗效和安全性：ROMANTIC（瑞舒伐他汀-OMAcor 在残余高甘油三酯血症中的应用），一项随机、双盲、安慰剂对照试验。

Clin Ther. 2018 Jan;40(1):83-94. doi: 10.1016/j.clinthera.2017.11.007. Epub 2017 Dec 7.

Suppr 超能文献

文献检索

文件翻译

深度研究

Suppr 超能文献

文献检索

文件翻译

深度研究

勘误：匹伐他汀和ω-3脂肪酸乙酯对接受他汀类药物治疗的血脂异常患者载脂蛋白B-48的影响：一项在日本进行的前瞻性、多中心、开放标签、随机、平行组试验（PROUD48研究）。

Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study).

作者信息

机构信息

出版信息